New shot could ease painful skin condition
NCT ID NCT06411899
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called sonelokimab, given as a shot under the skin, in 422 adults with moderate to severe hidradenitis suppurativa (a painful skin condition causing boils and abscesses). Participants were randomly assigned to receive either the drug or a placebo for up to 16 weeks. The main goal was to see if the drug could reduce the number of inflamed lumps by at least 75%.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sonelokimab (a drug given as a shot under the skin)
What this could lead to
If it works, this could provide a new treatment option for people with moderate to severe hidradenitis suppurativa, reducing painful lumps and abscesses.
What could go wrong
This is a completed Phase 3 trial, but results are not yet public. The drug may not work better than placebo, and side effects are possible. It is not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical SIte
Pleven, 5800, Bulgaria
-
Clinical SIte
Halle, 06108, Germany
-
Clinical Site
Los Angeles, California, 90024, United States
-
Clinical Site
Northridge, California, 91325, United States
-
Clinical Site
Sacramento, California, 95815, United States
-
Clinical Site
San Diego, California, 92123, United States
-
Clinical Site
Coral Gables, Florida, 33134, United States
-
Clinical Site
Coral Springs, Florida, 33071, United States
-
Clinical Site
Hollywood, Florida, 33201, United States
-
Clinical Site
Margate, Florida, 33063, United States
-
Clinical Site
Miami, Florida, 33161, United States
-
Clinical Site
Tampa, Florida, 33607, United States
-
Clinical Site
Macon, Georgia, 31217, United States
-
Clinical Site
Sandy Springs, Georgia, 30328, United States
-
Clinical Site
West Dundee, Illinois, 60118, United States
-
Clinical Site
Columbus, Indiana, 47201, United States
-
Clinical Site
New Albany, Indiana, 47150, United States
-
Clinical Site
Louisville, Kentucky, 40241, United States
-
Clinical Site
Metairie, Louisiana, 70006, United States
-
Clinical Site
Boston, Massachusetts, 02116, United States
-
Clinical Site
Boston, Massachusetts, 02215, United States
-
Clinical Site
Dearborn, Michigan, 48126, United States
-
Clinical Site
Warren, Michigan, 48088, United States
-
Clinical Site
Las Vegas, Nevada, 89119, United States
-
Clinical Site
New York, New York, 10012, United States
-
Clinical Site
The Bronx, New York, 10467, United States
-
Clinical Site
Boardman, Ohio, 44512, United States
-
Clinical Site
Dayton, Ohio, 45324, United States
-
Clinical Site
Mayfield Heights, Ohio, 44124, United States
-
Clinical Site
Oklahoma City, Oklahoma, 73118, United States
-
Clinical Site
Charleston, South Carolina, 29425, United States
-
Clinical Site
Nashville, Tennessee, 37215, United States
-
Clinical Site
Frisco, Texas, 75034, United States
-
Clinical Site
Houston, Texas, 77004, United States
-
Clinical Site
Houston, Texas, 77082, United States
-
Clinical Site
South Jordan, Utah, 84095, United States
-
Clinical Site
Forest, Virginia, 24551, United States
-
Clinical Site
Mill Creek, Washington, 98012, United States
-
Clinical Site
Sofia, 1407, Bulgaria
-
Clinical Site
Sofia, 1527, Bulgaria
-
Clinical Site
Sofia, 1606, Bulgaria
-
Clinical Site
Edmonton, Alberta, T5J 3S9, Canada
-
Clinical Site
Edmonton, Alberta, T6H 4J8, Canada
-
Clinical Site
Sherwood Park, Alberta, T8H 0P1, Canada
-
Clinical Site
Winnipeg, Manitoba, R3M 3Z4, Canada
-
Clinical Site
Fredericton, New Brunswick, E3B 1G9, Canada
-
Clinical Site
Barrie, Ontario, L4M 7G1, Canada
-
Clinical Site
London, Ontario, N6H 5L5, Canada
-
Clinical Site
Markham, Ontario, L3P 1X3, Canada
-
Clinical Site
Newmarket, Ontario, L3Y 5G8, Canada
-
Clinical Site
Toronto, Ontario, M2N 3A6, Canada
-
Clinical Site
Toronto, Ontario, M5A3R6, Canada
-
Clinical Site
Montreal, Quebec, H1Y 3L1, Canada
-
Clinical Site
Québec, Quebec, G1W 4R4, Canada
-
Clinical Site
Sherbrooke, Quebec, J1G 1X9, Canada
-
Clinical Site
Berlin, 10789, Germany
-
Clinical Site
Bochum, 44805, Germany
-
Clinical Site
Buxtehude, 21614, Germany
-
Clinical Site
Erlangen, 91054, Germany
-
Clinical Site
Essen, 45147, Germany
-
Clinical Site
Frankfurt, 60590, Germany
-
Clinical Site
Hanover, 30159, Germany
-
Clinical Site
Langenau, 89129, Germany
-
Clinical Site
Mahlow, 15831, Germany
-
Clinical Site
München, 80337, Germany
-
Clinical Site
Münster, 48149, Germany
-
Clinical Site
Oldenburg, 26133, Germany
-
Clinical Site
Wuppertal, 42283, Germany
-
Clinical Site
Budapest, 1036, Hungary
-
Clinical Site
Debrecen, 4031, Hungary
-
Clinical Site
Debrecen, 4032, Hungary
-
Clinical Site
Pécs, 7632, Hungary
-
Clinical Site
Brescia, 25123, Italy
-
Clinical Site
Catania, 95123, Italy
-
Clinical Site
Chieti, 66100, Italy
-
Clinical Site
Cona, 44124, Italy
-
Clinical Site
Florence, 50125, Italy
-
Clinical Site
Milan, 20122, Italy
-
Clinical Site
Modena, 41124, Italy
-
Clinical Site
Naples, 80131, Italy
-
Clinical Site
Perugia, 06129, Italy
-
Clinical Site
Pisa, 56126, Italy
-
Clinical Site
Rome, 00168, Italy
-
Clinical Site
Rozzano, 20089, Italy
-
Clinical Site
Torino, 10126, Italy
-
Clinical Site
Torrette, 60020, Italy
-
Clinical Site
Oslo, 0372, Norway
-
Clinical Site
Bialystok, 15-453, Poland
-
Clinical Site
Gdansk, 80-214, Poland
-
Clinical Site
Krakow, 30-002, Poland
-
Clinical Site
Krakow, 30-727, Poland
-
Clinical Site
Lodz, 90-265, Poland
-
Clinical Site
Lodz, 90-436, Poland
-
Clinical Site
Lublin, 20-573, Poland
-
Clinical Site
Ossy, 42-624, Poland
-
Clinical Site
Poznan, 60-529, Poland
-
Clinical Site
Sosnowiec, 41-200, Poland
-
Clinical Site
Szczecin, 71-500, Poland
-
Clinical Site
Warsaw, 00-710, Poland
-
Clinical Site
Warsaw, 02-507, Poland
-
Clinical Site
Warsaw, 02-692, Poland
-
Clinical Site
Wroclaw, 51-503, Poland
-
Clinical Site
Lisbon, 1169-050, Portugal
-
Clinical Site
Lisbon, 1649-035, Portugal
-
Clinical Site
Porto, 4050-342, Portugal
-
Clinical Site
Cardiff, CF14 4XW, United Kingdom
-
Clinical Site
Dudley, DY1 2HQ, United Kingdom
-
Clinical Site
Leeds, LS9 7TF, United Kingdom
-
Clinical Site
Salford, M6 8HD, United Kingdom